• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Investig Med High Impact Case Rep . Catastrophic Neurological Complications in 2 Patients With Sickle Cell Disease and COVID-19

tetano

Editor, Senior Moderator
J Investig Med High Impact Case Rep


. 2022 Jan-Dec;10:23247096221111778.
doi: 10.1177/23247096221111778.
Catastrophic Neurological Complications in 2 Patients With Sickle Cell Disease and COVID-19


Karen Clarke[SUP] 1 [/SUP], Karima Benameur[SUP] 2 [/SUP], Zanthia Wiley[SUP] 1 [/SUP], Yoo Mee Shin[SUP] 1 [/SUP], Mohamad Moussa[SUP] 1 [/SUP], Fuad El Rassi[SUP] 3 [/SUP], Morgan McLemore[SUP] 3 [/SUP]



Affiliations

Abstract

Severe acute respiratory syndrome coronavirus (SARS-CoV-2) infection is commonly associated with neurological complications. Patients with sickle cell disease are at increased risk of developing neurologic complications throughout their lifetimes and often have underlying cardiopulmonary comorbidities that may predispose them to poor outcomes during serious infections. In this case series, we describe 2 patients with sickle cell disease who developed devastating neurologic complications following SARS-CoV-2 infection, which ultimately led to brain edema and death. We highlight the unusual manifestations of coronavirus disease 2019 in patients with sickle cell disease and address the risk of these patients to develop catastrophic neurologic injury due to COVID-19, if not recognized promptly.

Keywords: COVID-19; neurological complications; sickle cell.
 
Back
Top Bottom